Xinxin Xu

Also affiliated with Lanzhou Institute of Chemical Physics, Zhejiang University

Agricultural and Biological SciencesEngineeringImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403.”.

Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10520

N/A

0.104DataRank · unranked

1 citations

Lingyun Ji, Xinxin Xu, Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas +10 more

Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group AALL1331 trial

Haematologica(2025)10.3324/haematol.2025.287386

N/A

0DataRank · unranked

0 citations

Teena Bhatla, Xinxin Xu, Lia Gore, Elizabeth A. Raetz, Deepa Bhojwani +6 more